View More View Less
  • 1 K.V.S.R Siddhartha College of Pharmaceutical Sciences, Vijayawada, 520010, AP, India
Restricted access

Summary

A simple, precise, rapid, and accurate liquid chromatography-mass spectrometry (LC-MS) compatible reversed phase high-performance liquid chromatography-photodiode array detection (RP-HPLC-PDA) method has been developed and validated for the estimation of oxcarbazepine (OXC) in bulk and tablet formulations. The chromatographic separation was achieved on Phenomenex C18 column (150 mm · 4.6 mm, 5.0 μm particle size) using the mobile phase comprising methanol-formic acid (0.02% v/v in water) in the ratio of 50:50 (v/v) at a flow rate of 1 mL min−1, and OXC was eluted at 6.4 min. Quantification and linearity were achieved at 229 nm over the concentration range of 10–50 μg mL−1, and the mean percentage of assay was found to be 100.03. The method was validated for specificity, linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), stability, and robustness as per the International Conference on Harmonisation (ICH) guidelines and it is suitable to be employed in quality control.

  • [1]. E.S. Tecoma 1999 Epilepsis 40 S37.

  • [2]. M.J. Mclean M. Schmutz A.W. Wamil 1994 Epilepsis 35 S5S9.

  • [3]. L.U. Zhi-cheng Y.U. Qing-sheng 2003 Chin. J. Clin. Pharmacol. 19 134137.

  • [4]. M. Mazza G. Della Marca M. D. Nicola G. Martinotti G. Pozzi L. Janiri P. Bria S. Mazza 2007 Epilepsy Behav. 10 397401.

  • [5]. A.R. Rosa N. Cruz M. Comes E. Vieta 2009 Euro. Neuropsychopharmacol. 19 S75S76.

  • [6]. K. Lanckmans R. Clinckers A. V. Eeckhaut S. Sarre I. Smolders Y.J. Michotte 2006 J. Chromatogr. B 831 205212.

  • [7]. H. Levert P. Odou H. Robert 2002 Biomed. Chromatogr. 16 1924.

  • [8]. H. Levert P. Odou H. Robert 2002 J. Pharm. Biomed. Anal. 28 517525.

  • [9]. R. Mandrioli N. Ghedini F. Albani E. Kenndler M.A. Raggi 2003 J. Chromatogr. B 783 253263.

  • [10]. H. Breton M. Cociglio F. Bressolle H. Peyriere J.P. Blayac D. Hillaire-Buys 2005 J. Chromatogr. B 828 8090.

  • [11]. M.C. Rouan M. Decherf V. Le Clanche J.B. Lecaillon J. Godbillon 1994 J. Chromatogr. B 658 167172.

  • [12]. G. Menge J.P. Dubois 1983 J. Chromatogr. B 275 189194.

  • [13]. G. Paglia O. D'Apolito D. Garofalo C. Scarano G. Corso 2007 J. Chromatogr. B 860 153159.

  • [14]. B.S. Maria F.N. Demetrius L.M. Ismael N.C. Adriano E.G. Francisco A.F. Fernando 2007 J. Pharm. Biomed. Anal. 45 304311.

  • [15]. M.L. Qi P. Wang L.J. Wang R.N. Fu 2003 J. Pharm. Biomed. Anal. 31 5762.

  • [16]. A. A. Rao 2008 Afr. J. Pure Appl. Chem. 2 15.

  • [17]. K.S. Rao N. Belorkar M.E.B. Rao 2009 J. Young Pharmacists 1 270277.

  • [18]. D.B. Pathare A.S. Jadhav M.S. Shingare 2007 J. Pharm. Biomed. Anal. 43 18251830.

  • [19]. H. Levert P. Odou H. Robert 2002 J. Pharm. Biomed. Anal. 28 517525.

  • [20]. Guidance for Industry — Q2B Validation of Analytical Procedures: Methodology; http://www.fda.gov/cder/guidance/index.htm.

All Time Past Year Past 30 Days
Abstract Views 21 21 2
Full Text Views 3 0 0
PDF Downloads 1 0 0